Skip to main content

Advertisement

SpringerLink
Log in

Screening of high-risk groups for breast and ovarian cancer in Europe: a focus on the Jewish population

  • Review
  • Published:
Oncology Reviews

Abstract

Low breast cancer screening rates are often found among ethnic minority groups and those born outside the host country. This is of particular concern for high-risk groups, who should benefit from ongoing trials aimed at optimizing screening strategies for breast, as well as ovarian cancer. Both of these issues are germane for Jewish women in Europe. We systematically review the literature concerning breast cancer early detection practices (BCEDP) among Jewish women, and examine European surveillance studies of high-risk for breast and/or ovarian cancer that had imaging in the surveillance protocol, in order to assess the likelihood of adequately including women from minority ethnic groups. No studies were found about BCEDP among Jewish women in Europe. Twenty-one research groups from Israel or the US addressed BCEDP among Jewish women. Some Jewish women in the US and Israel, including recent immigrants, are under-screened. Twenty-four research groups reported imaging surveillance of women at increased risk for breast and/or ovarian cancer in Europe. There was a clear benefit to magnetic resonance imaging and/or more intensive screening for women with increased breast cancer risk. Some of these surveillance studies considered ethnic minority groups at high risk, including Jewish women, but none provided adequate outreach to ensure that these groups were included in their programs. The specific screening needs of Jewish and other high-risk ethnic minority groups in Europe have not been met regarding breast and ovarian cancer. A European-wide, population-based approach is suggested, with cultural sensitivity being vital for these efforts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Notes

  1. However, the National Center for Disease Control, the National Health Survey in Israel, publication 237. Ministry of Health: Jerusalem, 2004 (Hebrew). http://www.health.gov.il/download/pages/woman_icdc.pdf cited the figure of 80.6% for self-reported adherence to biannual mammography screening among the overall Jewish population of women aged 50 or older.

References

  1. Parkin DM, Bray F, Pisani P (2005) Global cancer statistics. CA Cancer J Clin 55:74–108

    Article  PubMed  Google Scholar 

  2. Perry N, Broeders C, Törnberg S, Holland R, von Karsa L (2008) European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition–summary document. Ann Oncol 19:614–622

    Article  CAS  PubMed  Google Scholar 

  3. Boyle P, Leon ME, Maisonneuve P, Autier P (2003) Cancer control in women: update 2003. Int J Gyneacol Obstet 83(Suppl 1):179–202

    Article  Google Scholar 

  4. Brewer MA, Johnson K, Follen M, Gershenson D, Bast R (2003) Prevention of ovarian cancer: intraepithelial neoplasia. Clin Cancer Res 9:20–30

    CAS  PubMed  Google Scholar 

  5. Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih IeM (2008) Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. Am J Obstet Gynecol 198:351–356

    Article  PubMed  Google Scholar 

  6. Woodward ER, Sleightholme HV, Considine AM, Williamson S, McHugo JM, Cruger DG (2007) Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective. BJOG 114:1500–1509

    Article  CAS  PubMed  Google Scholar 

  7. Belkić Dž, Belkić K (2008) Mathematical modeling applied to an NMR problem in ovarian cancer detection. J Math Chem 43:395–425

    Article  CAS  Google Scholar 

  8. Bosse K, Rhiem K, Wappenschmidt B, Hellmich M, Madeja M, Ortmann M et al (2006) Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study. Gynecol Oncol 103:1077–1082

    Article  CAS  PubMed  Google Scholar 

  9. Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R et al (2008) A randomized study of screening for ovarian cancer: a multicenter study in Japan. Int J Gynecol Cancer 18:414–420

    Article  CAS  PubMed  Google Scholar 

  10. Nossov V, Amneus M, Su F, Lang J, Janco JM, Reddy ST et al (2008) The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125? Am J Obstet Gynecol 199:215–223

    Article  CAS  PubMed  Google Scholar 

  11. Armstrong K, Moye E, Williams S, Berlin JA, Reynolds EE (2007) Screening mammography in women 40 to 49 years of age: a systematic review for the American College of Physicians. Ann Intern Med 146:516–526

    PubMed  Google Scholar 

  12. Saslow D, Boetes C, Burke W, Harms S, Leach MO, Lehman CD et al (2007) American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75–89

    Article  PubMed  Google Scholar 

  13. Morimoto T, Nagao T, Okazaki K, Kira M, Nakagawa Y, Tangoku A (2009) Current status of breast cancer screening in the world. Breast Cancer 16:2–9

    Article  PubMed  Google Scholar 

  14. Tabár L, Vitak B, Yen MF, Chen HH, Smith RA, Duffy SW (2004) Number needed to screen: lives saved over 20 years of follow-up in mammographic screening. J Med Screen 11:126–129

    Article  PubMed  Google Scholar 

  15. Sant M, Allemani C, Capocaccia R, Hakulinen T, Aareleid T, Coebergh JW et al (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106:416–422

    Article  CAS  PubMed  Google Scholar 

  16. Sarkeala T, Anttila A, Saarenmaa I, Hakama M (2005) Validity of process indicators of screening for breast cancer to predict mortality reduction. J Med Screen 12:33–37

    Article  CAS  PubMed  Google Scholar 

  17. MacDonald DJ, Sarna L, Uman GC, Grant M, Weitzel JN (2006) Cancer screening and risk–reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers. Oncol Nurs Forum 33:E27–E35

    Article  PubMed  Google Scholar 

  18. Sabatino SA, Burns RB, Davis RB, Phillips RS, Chen YH, McCarthy EP (2004) Breast carcinoma screening and risk perception among women at increased risk for breast carcinoma: results from a national survey. Cancer 100:2338–2346

    Article  PubMed  Google Scholar 

  19. Cohen M (2006) Breast cancer early detection, health beliefs and cancer worries in randomly selected women with and without a family history of breast cancer. Psychooncology 15:878–883

    Google Scholar 

  20. Isaacs C, Peshkin BN, Schwartz M, Demarco TA, Main D, Lerman C (2002) Breast and ovarian cancer screening practices in healthy women with a strong family history of breast or ovarian cancer. Breast Cancer Res Treat 71:103–112

    Article  PubMed  Google Scholar 

  21. Meiser B, Butow P, Barratt A, Friedlander M, Kirk J, Gaff C et al (2000) Breast cancer screening uptake in women at increased risk of developing hereditary breast cancer. Breast Cancer Res Treat 59:101–111

    Article  CAS  PubMed  Google Scholar 

  22. Antill YC, Reynolds J, Young MA, Kirk JA, Tucker KM, Bogtstra TL et al (2006) Screening behavior in women at increased familial risk for breast cancer. Fam Cancer 5:359–368

    Article  PubMed  Google Scholar 

  23. Evans JP, Skrzynia C, Susswein L, Harlan M (2005–2006) Genetics and the young woman with breast cancer. Breast Dis 23:17–29

    Google Scholar 

  24. Weitzel JN, Lagos VI, Cullinane CA, Gambol PJ, Culver JO, Blazer KR et al (2007) Limited family structure and BRCA gene mutation status in single cases of breast cancer. JAMA 297:2587–2595

    Article  CAS  PubMed  Google Scholar 

  25. Kurian AW, Hartman AR, Mills MA, Ford JM, Daniel BL, Plevritis SK (2005) Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: an initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expect 8:221–233

    Article  PubMed  Google Scholar 

  26. Clements A, Henderson BJ, Tyndel S, Evans G, Brian K, Austoker J et al (2007) Diagnosed with breast cancer while on a family history screening programme: an exploratory qualitative study. Eur J Cancer Care 17:245–252

    Article  Google Scholar 

  27. Bermejo-Perez MJ, Marquez-Calderon S, Llanos-Mendez A (2008) Cancer surveillance based on imaging techniques in carriers of BRCA1/2 gene mutations: a systematic review. Br J Radiol 81:172–179

    Article  CAS  PubMed  Google Scholar 

  28. Calderon-Margalit R, Paltiel O (2004) Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. Int J Cancer 112:357–364

    Article  CAS  PubMed  Google Scholar 

  29. Willey SC, Cocilovo C (2007) Screening and follow-up of the patient at high risk for breast cancer. Obstet Gynecol 110:1404–1416

    PubMed  Google Scholar 

  30. Anderson E, Berg J, Black R, Bradshaw N, Campbell J, Cetnarskyj R et al (2008) Predicting breast cancer risk: implications of a “weak” family history. Fam Cancer 7:361–366

    Article  PubMed  Google Scholar 

  31. Eerola H, Blomqvist C, Pukkala E, Pyrhonen S, Nevanlinna H (2000) Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? Eur J Cancer 36:1143–1148

    Article  CAS  PubMed  Google Scholar 

  32. Møller P, Hagen AI, Apold J, Maehle L, Clark N, Fiane B et al (2007) Genetic epidemiology of BRCA mutations—family history detects less than 50% of the mutation carriers. Eur J Cancer 43:1713–1717

    Article  PubMed  CAS  Google Scholar 

  33. Leu M, Czene K, Reilla M (2007) The impact of truncation and missing family links in population-based registers on familial risk estimates. Am J Epidemiol 166:1461–1467

    Article  PubMed  Google Scholar 

  34. Cohen M, Azaiza F (2005) Early breast cancer detection practices, health beliefs and cancer worries in Jewish and Arab women. Prev Med 41:852–858

    Article  PubMed  Google Scholar 

  35. Goel SM, Wee CC, McCarthy EP, Davis RB, Ngo-Metzger Q, Phillips RS (2003) Racial and ethnic disparities in cancer screening: the importance of foreign birth as a barrier to care. J Gen Intern Med 18:1028–1035

    Article  PubMed  Google Scholar 

  36. Lagerlund M, Maxwell AE, Bastani R, Thurfjell E, Ekbom A, Lambe M (2002) Sociodemographic predictors of non-attendance at invitational mammography screening—a population based register study (Sweden). Cancer Cause Control 13:73–82

    Article  Google Scholar 

  37. Sassi F, Luft HS, Guadagnoli E (2006) Reducing racial/ethnic disparities in female breast cancer: screening rates and stage at diagnosis. Am J Public Health 96:2165–2172

    Article  PubMed  Google Scholar 

  38. Terán L, Baezconde-Garbanati L, Márquez M, Castellanos E, Belkić K (2007) On-time mammography screening with a focus on Latinas with low income: a proposed cultural model. Anti-Cancer Res 27:4325–4338

    Google Scholar 

  39. Beiki O, Allebeck P, Nordqvist T, Moradi T (2009) Cervical, endometrial and ovarian cancers among immigrants in Sweden: importance of age at migration and duration of residence. Eur J Cancer 45:107–118

    Article  PubMed  Google Scholar 

  40. Belkić K (2004) Current dilemmas and future perspectives for breast cancer screening with a focus upon optimization of magnetic resonance spectroscopic imaging by advances in signal processing. Isr Med Assoc J 6:610–618

    PubMed  Google Scholar 

  41. Fackenthal JD, Olopade OI (2007) Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations. Nat Rev Cancer 7:937–948

    Article  CAS  PubMed  Google Scholar 

  42. Shkolnikov VM, Andreev EM, Anson J, Mesle F (2004) The peculiar pattern of mortality of Jews in Moscow, 1993–95. Popul Stud 58:311–329

    Article  Google Scholar 

  43. Hampel H, Sweet K, Westman JA, Offit K, Eng C (2004) Referral for cancer genetics consultation: a review and compilation of risk assessment criteria. J Med Genet 41:81–91

    Article  CAS  PubMed  Google Scholar 

  44. National Comprehensive Cancer Network (2007) Clinical practice guidelines in oncology. Genetic/familial high-risk assessment: breast and ovarian. http://www.nccn.org

  45. Barnoy S, Bar-Tal Y, Treister L (2003) Effect of unrealistic optimism, perceived control over disease, and experience with female cancer on behavioral intentions of Israeli women to undergo screening tests. Cancer Nurs 26:363–369

    Article  PubMed  Google Scholar 

  46. Baron-Epel O, Friedman N, Lernau O (2008) Validity of self-reported mammography in a multicultural population in Israel. Prev Med 46:489–491

    Article  PubMed  Google Scholar 

  47. Baron-Epel O, Friedman N, Lernau O (2009) Fatalism and mammography in a multicultural population. Oncol Nurs Forum 36:353–361

    Article  PubMed  Google Scholar 

  48. Bentur N, Gross R, Berg A (1998) Screening tests for early detecting breast cancer in women in Israel—performance rates and patient characteristics. Harefuah 134:425–428, 504

    CAS  PubMed  Google Scholar 

  49. Cohen M (2002) First-degree relatives of breast-cancer patients: cognitive perceptions, coping and adherence to breast self-examination. Behav Med 28:15–22

    Article  PubMed  Google Scholar 

  50. Eilat-Tsanani S, Sorek M, Gay N, Chaimovitch O, Kulton L, Tabenkin H (2001) Family physicians’ initiative to increase compliance with screening mammography—an innovative community project. Isr Med Assoc J 3:920–924

    CAS  PubMed  Google Scholar 

  51. Giveon S, Kahan E (2000) Patient adherence to family practitioners’ recommendations for breast cancer screening: a historical cohort study. Fam Pract 17:42–45

    Article  CAS  PubMed  Google Scholar 

  52. Hagoel L, Ore L, Neter E, Shifroni G, Rennert G (1999) The gradient in mammography screening behavior: a lifestyle marker. Soc Sci Med 48:1281–1290

    Article  CAS  PubMed  Google Scholar 

  53. Hagoel L, Neter E, Dishon S, Barnett O, Rennert G (2003) BRCA1/2 mutation carriers: living with susceptibility. Community Genet 6:242–248

    Article  PubMed  Google Scholar 

  54. Keinan-Boker L, Baron-Epel O, Garty N, Green MS (2003) Family history of breast cancer and compliance with mammography in Israel: findings of the National Health Survey 2003–2004 (EUROHIS). Eur J Cancer Prev 16:43–49

    Article  Google Scholar 

  55. Kreitler S, Chaitchik S, Kreitler H (1990) The psychological profile of women attending breast-screening tests. Soc Sci Med 31:1177–1185

    Article  CAS  PubMed  Google Scholar 

  56. Lubish L, Greenberg S, Friger M, Shvartzman P (2001) Breast cancer screening in two multicultural family practice teaching clinics. Isr Med Assoc J 3:579–583

    CAS  PubMed  Google Scholar 

  57. Ore L, Hagoel L, Shifroni G, Rennert G (1997) Compliance with mammography screening in Israeli women: the impact of a pre-scheduled appointment and of the letter-style. Isr J Med Sci 33:103–111

    CAS  PubMed  Google Scholar 

  58. Remennick L (1999) Preventive behavior among recent immigrants: Russian-speaking women and cancer screening in Israel. Soc Sci Med 48:1669–1684

    Article  CAS  PubMed  Google Scholar 

  59. Remennick L (1999) Breast screening practices among Russian immigrant women in Israel. Women Health 28:29–51

    Article  CAS  PubMed  Google Scholar 

  60. Remennick L (2003) “I have no time for potential troubles”: Russian immigrant women and breast cancer screening in Israel. J Immigr Health 5:153–163

    Article  PubMed  Google Scholar 

  61. Slater PE, Aviram H, Dagan M, Yosselson-Superstine S, Cristal R, Rubinstein I et al (1990) Breast cancer screening in Tel Aviv. Eur J Epidemiol 6:253–256

    Article  CAS  PubMed  Google Scholar 

  62. DiCastro M, Frydman M, Friedman I, Shiri-Sverdlov R, Papa MZ, Goldman B et al (2002) Genetic counseling in hereditary breast/ovarian cancer in Israel: psychosocial impact and retention of genetic information. Am J Med Genet 111:147–151

    Article  PubMed  Google Scholar 

  63. Albert SM, Harlap S, Caplan L (2004) Cancer screening among older women in a culturally insular community. Prev Med 39:649–656

    Article  PubMed  Google Scholar 

  64. Bowen DJ, Singal R, Eng E, Crystal S, Burke W (2003) Jewish identity and intentions to obtain breast cancer screening. Cultur Divers Ethnic Minor Psycho 9:79–87

    Article  Google Scholar 

  65. Goodwin SS, Visintainer PF, Facelle J, Falvo CE (2006) Breast cancer screening in Rockland County, New York: a survey of attitudes and behaviors. Ethnic Dis 16:428–434

    Google Scholar 

  66. Plon SE, Peterson LE, Friedman LC, Richards CS (2000) Mammography behavior after receiving a negative BRCA1 mutation test result in the Ashkenazim: a community-based study. Genet Med 2:307–311

    CAS  PubMed  Google Scholar 

  67. Armstrong K, Calzone K, Stopfer J, Fitzgerald G, Coyne J, Weber B (2000) Factors associated with decisions about clinical BRCA1/2 testing. Cancer Epidemiol Biomarkers Prev 9:1251–1254

    CAS  PubMed  Google Scholar 

  68. Bowen DJ, Burke W, Culver JO, Press N, Crystal S (2006) Effects of counseling Ashkenazi Jewish women about breast cancer risk. Cult Divers Ethnic Min Psychol 12:45–56

    Article  Google Scholar 

  69. Bowen DJ, Bourcier E, Press N, Lewis FM, Burke W (2004) Effects of individual and family functioning on interest in genetic testing. Community Genet 7:25–32

    Article  PubMed  Google Scholar 

  70. Culver J, Burke W, Yasui Y, Durfy S, Press N (2001) Participation in breast cancer genetic counseling: the influence of educational level, ethnic background, and risk perception. J Genet Counsel 10:215–231

    Article  Google Scholar 

  71. Durfy S, Bowen D, McTiernan A, Spoleder J, Burke W (1999) Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington. Cancer Epidemiol Biomarkers Prev 8(Pt. 2):369–375

    CAS  PubMed  Google Scholar 

  72. Friedman LC, Webb JA, Richards CS, Lynch GR, Kaplan AL, Brunicardi FC, Plon SE (1999) Psychological impact of receiving negative BRCA1 mutation test results in Ashkenazim. Genet Med 1:74–79

    Article  CAS  PubMed  Google Scholar 

  73. Lehmann LS, Weeks JC, Klar N, Garber JE (2002) A population-based study of Ashkenazi Jewish women’s attitudes toward genetic discrimination and BRCA1/2 testing. Genet Med 4:346–352

    Article  PubMed  Google Scholar 

  74. Lehmann LS, Weeks JC, Klar N, Biener L, Garber JE (2000) Disclosure of familial genetic information: perceptions of the duty to inform. Am J Med 109:705–711

    Article  CAS  PubMed  Google Scholar 

  75. Press NA, Yasui Y, Reynolds S, Durfy SJ, Burke W (2001) Women’s interest in genetic testing for breast cancer susceptibility may be based on unrealistic expectations. Am J Med Genet 99:99–110

    Article  CAS  PubMed  Google Scholar 

  76. Andrews L, Meiser B, Apicella C, Tucker K (2004) Psychological impact of genetic testing for breast cancer susceptibility in women of Ashkenazi Jewish background: a prospective study. Genet Test 8:240–247

    Article  PubMed  Google Scholar 

  77. Apicella C, Peacock SJ, Andrews L, Tucker K, Bankier A, Daly MB et al (2006) Determinants of preferences for genetic counseling in Jewish women. Fam Cancer 5:159–167

    Article  PubMed  Google Scholar 

  78. Peacock S, Apicella C, Andrews L, Tucker K, Bankier A, Daly MB et al (2006) A discrete choice experiment of preferences for genetic counseling among Jewish women seeking cancer genetics services. Br J Cancer 95:1448–1453

    Article  CAS  PubMed  Google Scholar 

  79. Israel Central Bureau of Statistics (2008) Statistical abstract of Israel: localities, population and density per sq. km., by metropolitan area and selected localities (Number 2.6). Jerusalem, Israel

  80. Essink-Bot ML, Rijnsburger AJ, van Dooren S, de Koning HJ, Seynaeve C (2006) Women’s acceptance of MRI in breast cancer surveillance because of a familial or genetic predisposition. Breast 15:673–676

    Article  CAS  PubMed  Google Scholar 

  81. Kriege M, Brekelmans CT, Boetes C, Rutgers EJT, Oosterwijk JC, Tollenaar RAEM et al (2001) MRI screening for breast cancer in women with familial or genetic predisposition: design of the Dutch National Study (MRISC). Fam Cancer 1:163–168

    Article  CAS  PubMed  Google Scholar 

  82. Kriege M, Brekelmans C, Boetes C, Besnard PE, Zonderland HM, Obdeijn IM et al (2004) Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 351:427–437

    Article  CAS  PubMed  Google Scholar 

  83. Kriege M, Brekelmans CT, Boetes C, Muller SH, Zonderland HM, Obdeijn IM et al (2006) Differences between first and subsequent rounds of the MRISC breast cancer screening program for women with a familial or genetic predisposition. Cancer 106:2318–2326

    Article  PubMed  Google Scholar 

  84. Kriege M, Brekelmans CT, Peterse H, Obdeijn IM, Boetes C, Zonderland HM et al (2007) Tumor characteristics and detection method in the MRISC screening program for the early detection of hereditary breast cancer. Breast Cancer Res Treat 102:357–363

    Article  CAS  PubMed  Google Scholar 

  85. Pieterse K, van Dooren S, Seynaeve C, Bartels CC, Rijnsburger AJ, de Koning HJ et al (2007) Passive coping and psychological distress in women adhering to regular breast cancer surveillance. Psychooncology 16:851–858

    Article  CAS  PubMed  Google Scholar 

  86. Tilanus-Linthorst MM, Kriege M, Boetes C, Hop WC, Obdeijn IM, Oosterwijk JC et al (2005) Hereditary breast cancer growth rates and its impact on screening policy. Eur J Cancer 41:1610–1617

    Article  PubMed  Google Scholar 

  87. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M (2000) First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 63:53–60

    Article  CAS  PubMed  Google Scholar 

  88. Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA et al (2000) Protocol for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. Breast 9:78–82

    Article  CAS  PubMed  Google Scholar 

  89. Brown J, Coulthard A, Dixon AK, Dixon JM, Easton DF, Eeles RA et al (2000) Rationale for a national multi-centre study of magnetic resonance imaging screening in women at genetic risk of breast cancer. Breast 9:72–77

    Article  CAS  PubMed  Google Scholar 

  90. Brown J, Buckley D, Coulthard A, Dixon AK, Dixon JM, Easton DF et al (2000) Magnetic resonance imaging screening in women at genetic risk of breast cancer: imaging and analysis protocol for the UK multicentre study. UK MRI Breast Screening Study Advisory Group. Magn Reson Imaging 18:765–776

    Article  CAS  PubMed  Google Scholar 

  91. Griebsch I, Brown J, Boggis C, Dixon A, Dixon M, Easton D et al (2006) Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer. Br J Cancer 95:801–810

    Article  CAS  PubMed  Google Scholar 

  92. Gui GP, Hogben RK, Walsh G, A’Hern R, Eeles R (2001) The incidence of breast cancer from screening women according to predicted family history risk: does annual clinical examination add to mammography? Eur J Cancer 37:1668–1673

    Article  CAS  PubMed  Google Scholar 

  93. Gui GP, Kadayaprath G, Darhouse N, Self J, Ward A, A’Hern R et al (2006) Clinical outcome and service implications of screening women at increased breast cancer risk from a family history. Eur J Surg Oncol 32:719–724

    Article  CAS  PubMed  Google Scholar 

  94. Leach MO, the MARIBS Advisory Group, Staff and Collaborating Centres (2002) The UK National study of magnetic resonance imaging as a method of screening for breast cancer (MARIBS). J Exp Clin Cancer Res 21(3 Suppl):107–114

    CAS  PubMed  Google Scholar 

  95. Leach MO, Boggis CR, Dixon AK, Easton DF, Eeles RA, Evans DG et al (2005) Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365:1769–1778

    Article  CAS  PubMed  Google Scholar 

  96. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC (2005) MARIBS study. Lancet 366:291–292

    Article  PubMed  Google Scholar 

  97. Warren RM, Thompson D, Pointon LJ, Hoff R, Gilbert FJ, Padhani AR et al (2006) Evaluation of a prospective scoring system designed for a multicenter breast MR imaging screening study. Radiology 239:677–685

    Article  PubMed  Google Scholar 

  98. Murday V, Pears R, Ball J, Eeles R, Hodgson S (2004) An audit of screening for familial breast cancer before 50 years in the South Thames Region—have we got it right? Fam Cancer 3:29–34

    Article  PubMed  Google Scholar 

  99. Kollias J, Sibbering DM, Blamey RW, Holland PA, Obuszko Z, Wilson AR et al (1998) Screening women aged less than 50 years with a family history of breast cancer. Eur J Cancer 34:878–883

    Article  CAS  PubMed  Google Scholar 

  100. Schmutzler RK, Rhiem K, Breuer P, Wardelmann E, Lehnert M, Coburger S et al (2006) Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer. Eur J Cancer Prevent 15:483–489

    Article  Google Scholar 

  101. Kuhl CK (2002) High-risk screening: multi-modality surveillance of women at high risk for breast cancer (proven or suspected carriers of a breast cancer susceptibility gene). J Exp Clin Cancer Res 21(Suppl):103–106

    CAS  PubMed  Google Scholar 

  102. Kuhl CK, Schrading S, Leutner CC, Markkabati-Spitz N, Wardelmann E, Fimmers R et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8476

    Article  PubMed  Google Scholar 

  103. Kuhl CK, Kuhn W, Schild H (2005) Management of women at high risk for breast cancer: new imaging beyond mammography. Breast 14:480–486

    Article  CAS  PubMed  Google Scholar 

  104. Schrading S, Kuhl CK (2008) Mammographic, US, and MR imaging phenotypes of familial breast cancer. Radiology 246:58–70

    PubMed  Google Scholar 

  105. Sardanelli F, Podo F, D’Agnolo G, Verdecchia A, Santaquilani M, Musumeci R et al (2007) Multicenter comparative multimodality surveillance of women at genetic-familial high risk for breast cancer (HIBCRIT study): interim results. Radiology 242:698–715

    Article  PubMed  Google Scholar 

  106. Cortesi L, Turchetti D, Marchi I, Fracca A, Canossi B, Rachele B et al (2006) Breast cancer screening in women at increased risk according to different family histories: an update of the Modena Study Group experience. BMC Cancer 6:210. doi:10.1186/1471-2407-6-210

    Article  PubMed  Google Scholar 

  107. Federico M, Maiorana A, Mangone L, Turchetti D, Canossi B, Cortesi L et al (1999) Identification of families with hereditary breast and ovarian cancer for clinical and mammographic surveillance: the Modena Study Group proposal. Breast Cancer Res Treat 55:213–221

    Article  CAS  PubMed  Google Scholar 

  108. Trecate G, Vergnaghi D, Manoukian S, Bergonzi S, Scaperrotta G, Marchesini M et al (2006) MRI in the early detection of breast cancer in women with high genetic risk. Tumori 92:517–523

    PubMed  Google Scholar 

  109. Gronwald J, Byrski T, Huzarski T, Cybulski C, Stawicka M, Szwiec M et al (2007) A survey of preventive measures among BRCA1 mutation carriers from Poland. Clin Genet 71:153–157

    Article  CAS  PubMed  Google Scholar 

  110. Górski B, Jakubowska A, Huzarski T, Byrski T, Gronwald J, Grzybowska E et al (2004) A high proportion of founder BRCA1 mutations in Polish breast cancer families. Int J Cancer 110:683–686

    Article  PubMed  CAS  Google Scholar 

  111. Daguet E, Malhaire C, Hardit C, Athanasiou A, El Khoury C, Thibault F et al (2008) MR breast screening in patients with genetic mutation. J Radiol 89:783–790

    Article  CAS  PubMed  Google Scholar 

  112. Riedl CC, Ponhold L, Flory D, Weber M, Kroiss R, Wagner T et al (2007) Magnetic resonance imaging of the breast improves detection of invasive cancer, pre-invasive cancer, and premalignant lesions during surveillance of women at high risk for breast cancer. Clin Cancer Res 13:6144–6152

    Article  PubMed  Google Scholar 

  113. Kroiss R, Winkler V, Kalteis K, Bikas D, Rudas M, Tea M et al (2008) Prevalence of pre-malignant and malignant lesions in prophylactic mastectomy specimens of BRCA1 mutation carriers: comparison with a control group. J Cancer Res Clin Oncol 134:1113–1121

    Article  PubMed  Google Scholar 

  114. Kroiss R, Winkler V, Bikas D, Fleischmann E, Mainau C, Frommlet F et al (2005) Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers. Hum Mutat 26:583–589

    Article  CAS  PubMed  Google Scholar 

  115. Dørum A, Kristensen GB, Abeler VM, Trope CG, Moller P (1996) Early detection of familial ovarian cancer. Eur J Cancer 32A:1645–1651

    Article  PubMed  Google Scholar 

  116. Dørum A, Heimdal K, Lovslett K, Kristensen G, Hansen LJ, Sandvei R et al (1999) Prospectively detected cancer in familial breast/ovarian cancer screening. Acta Obstet Gynecol Scand 78:906–911

    Article  PubMed  Google Scholar 

  117. Evans DG, Gaarenstroom KN, Stirling D, Shenton A, Maehle L, Dørum A et al (2009) Screening for familial ovarian cancer: poor survival of BRCA 1/2 cancers. J Med Genetics 46:593–597

    Article  CAS  Google Scholar 

  118. Gaarenstroom KN, van der Hiel B, Tollenaar RA, Vink GR, Jansen FW, van Asperen CJ et al (2006) Efficacy of screening women at high risk of hereditary ovarian cancer: results of an 11-year cohort study. Int J Gynecol Cancer 16(Suppl 1):54–59

    Article  PubMed  Google Scholar 

  119. Olivier RI, Lubsen-Brandsma MA, Verhoef S, van Beurden M (2006) CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecol Oncol 100:20–26

    Article  CAS  PubMed  Google Scholar 

  120. Oei AL, Massuger LF, Bulten J, Ligtenberg MJH, Hoogerbrugge NH, de Hullu JAH (2006) Surveillance of women at high risk for hereditary ovarian cancer is inefficient. Br J Cancer 27(94):814–819

    Article  Google Scholar 

  121. Jacobs IJ, Mackay J, Menon U, Skates SJ, Rosenthal AN, Fraser L (2006) Familial ovarian screening—effective or ineffective? Br J Cancer 95:1124

    Article  CAS  PubMed  Google Scholar 

  122. Menon U, Skates SJ, Lewis S, Rosenthal AN, Rufford B, Sibley K et al (2005) Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer. J Clin Oncol 23:7919–7926

    Article  PubMed  Google Scholar 

  123. Rieck GC, Lim K, Rogers MT, France E, Gray JR, Amso N et al (2006) Screening for familial ovarian cancer-management and outcome of women with moderate to high risk of developing ovarian cancer. Int J Gynecol Cancer 16(Suppl 1):86–91

    Article  PubMed  Google Scholar 

  124. Tailor A, Bourne T, Campbell S, Okokon E, Dew T, Collins WP (2003) Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study. Ultrasound Obstet Gynecol 21:378–385

    Article  CAS  PubMed  Google Scholar 

  125. Andolf E, Jorgensen C, Astedt B (1990) Ultrasound examination for detection of ovarian carcinoma in risk groups. Obstet Gynecol 75:106–109

    CAS  PubMed  Google Scholar 

  126. Andolf E (1993) Ultrasound screening in women at risk for ovarian cancer. Clin Obstet Gynecol 36:423–432

    Article  CAS  PubMed  Google Scholar 

  127. Arver B, Borg A, Lindblom A (2001) First BRCA1 and BRCA2 gene testing implemented in the health care system of Stockholm. Genet Test 5:1–8

    Article  CAS  PubMed  Google Scholar 

  128. Arver B, Haegermark A, Platten U, Lindblom A, Brandberg Y (2004) Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam Cancer 3:109–116

    Article  PubMed  Google Scholar 

  129. Zelada-Hedman M, Wasteson Arver B, Claro A, Chen J, Werelius B, Kok H et al (1997) A screening for BRCA1 mutations in breast and breast-ovarian cancer families from the Stockholm region. Cancer Res 57:2474–2477

    CAS  PubMed  Google Scholar 

  130. Lux MP, Ackermann S, Nestle-Krämling C, Goecke TO, Niederacher D, Bodden-Heidrich R et al (2005) Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer. Eur J Cancer Prev 14:399–411

    Article  CAS  PubMed  Google Scholar 

  131. Lux MP, Ackermann S, Bani MR, Nestle-Krämling C, Goecke TO, Niederacher D et al (2005) Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer. Eur J Cancer Prev 14:503–511

    Article  PubMed  Google Scholar 

  132. Hofvind S, Geller B, Vacek PM, Thoresen S, Skaane P (2007) Using the European guidelines to evaluate the Norwegian Breast Cancer Screening Program. Eur J Epidemiol 22:447–455

    Article  PubMed  Google Scholar 

  133. Calle EE, Flanders WD, Thun MJ, Martin LM (1993) Demographic predictors of mammography and Pap smear screening in US women. Am J Public Health 83:53–60

    CAS  PubMed  Google Scholar 

  134. Moy B, Park ER, Feibelmann S, Chiang S, Weissman JS (2006) Barriers to repeat mammography: Cultural perspectives of African-American, Asian and Hispanic women. Psychooncology 15:623–634

    Article  PubMed  Google Scholar 

  135. Trigoni M, Griffiths F, Tsiftsis D, Koumantakis E, Green E, Lionis C (2008) Mammography screening: views from women and primary care physicians in Crete. BMC Women’s Health 8:20. doi:10.1186/1472-6874-8-20

    Article  PubMed  Google Scholar 

  136. Fischera SD, Frank DI (1994) The health belief model as a predictor of mammography screening. Health Values 18:3–9

    Google Scholar 

  137. Montano D, Taplin S (1991) A test of an expanded theory of reasoned action to predict mammography participation. Soc Sci Med 32:733–741

    Article  CAS  PubMed  Google Scholar 

  138. Pasick R, Burke N (2008) A critical review of theory in breast cancer screening promotion across cultures. Annu Rev Public Health 29:351–368

    Article  PubMed  Google Scholar 

  139. Brandt RT, Lynch HT (2001) BRCA1 and BRCA2: to test or not to test. Breast Cancer Res Treat 67:187–188

    Article  CAS  PubMed  Google Scholar 

  140. Prochazka M, Hall P, Granath F, Czene K (2006) Family history of breast cancer and young age at diagnosis of breast cancer increase risk of second primary malignancies in women: a population-based cohort study. Br J Cancer 95:1291–1295

    Article  CAS  PubMed  Google Scholar 

  141. Brandt-Rauf SI, Raveis VH, Drummond NF, Conte JA, Rothman SM (2006) Ashkenazi Jews and breast cancer: the consequences of linking ethnic identity to genetic disease. Am J Public Health 96:1979–1988

    Article  PubMed  Google Scholar 

  142. Surbone A (2001) Ethical implications of genetic testing for breast cancer susceptibility. Crit Rev Oncol Hematol 40:149–157

    Article  CAS  PubMed  Google Scholar 

  143. Baider L, Peretz T, Ever-Hadani P, Perry S, Avramov R, Kaplan De-Nour A (2000) Transmission of response to trauma? Second-generation Holocaust survivors’ reaction to cancer. Am J Psychiatry 157:904–910

    Article  CAS  PubMed  Google Scholar 

  144. Baider L, Goldzweig G, Ever-Hadani P, Peretz T (2006) Psychological distress and coping in breast cancer patients and healthy women whose patients survived the Holocaust. Psychooncology 15:635–646

    Article  PubMed  Google Scholar 

  145. Baider L, Goldzweig G, Ever-Hadani P, Peretz T (2008) Breast cancer and psychological distress: mothers’ and daughters’ traumatic experiences. Support Care Cancer 16:407–414

    Article  PubMed  Google Scholar 

  146. Keinan-Boker L, Van-Raviv N, Liphshitz I, Linn S, Barchana M (2009) Cancer incidence in Israeli Jewish survivors of World War II. J Natl Cancer Inst 101:1489–1500

    Article  PubMed  Google Scholar 

  147. Newman LA, Hurd T, Leitch M, Kuerer HM, Diehl K, Lucci A et al (2004) A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group. J Am Coll Surg 199:644–651

    Article  PubMed  Google Scholar 

  148. Guevara C, Cook C, Herback N, Pietrobon R, Jacobs DO, Vail TP (2006) Gender, racial, and ethnic disclosure in NIH K-Award funded diabetes and obesity clinical trials. Acc Res 13:311–324

    Google Scholar 

  149. Erwin DO, Johnson VA, Trevino M, Duke K, Feliciano L, Jandorf L (2007) A comparison of African American and Latin social networks as indicators for culturally tailoring a breast and cervical cancer education intervention. Cancer 109(Suppl 2):368–377

    Article  PubMed  Google Scholar 

  150. Glanz K, Croyle RT, Chollette VY, Pinn VW (2003) Cancer-related health disparities in women. Am J Public Health 93:292–298

    Article  PubMed  Google Scholar 

  151. Meiser B, Eisenbruch M, Barlow-Stewart K, Tucker K, Steel Z, Goldstein D (2001) Cultural aspects of cancer genetics: setting a research agenda. J Med Genet 38:425–429

    Article  CAS  PubMed  Google Scholar 

  152. Cohen M, Azaiza F (2010) Increasing breast examination among Arab women using a tailored culture-based intervention. Behav Med (in press)

  153. Navarro AM, Senn KL, McNicholas LJ, Kaplan RM, Roppe B, Campo MC (1998) Por la Vida model intervention enhances use of cancer screening tests among Latinas. Am J Prev Med 15:32–41

    Article  CAS  PubMed  Google Scholar 

  154. U.S. Preventive Services Task Force (2004) Screening for ovarian cancer: recommendation statement. Ann Fam Med 2:260–262

    Article  Google Scholar 

  155. Buys SS, Partridge E, Greene MH, Prorok PC, Reding D, Riley TL et al (2005) Ovarian cancer screening in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial. Am J Obstet Gynecol 193:1630–1639

    Article  PubMed  Google Scholar 

  156. McGovern PM, Gross CR, Krueger RA, Engelhard DA, Cordes JE, Church TR (2004) False-positive cancer screens and health-related quality of life. Cancer Nurs 27:347–352

    Article  PubMed  Google Scholar 

  157. Yu J, Park A, Morris E, Liberman L, Borgen PI, King TA (2008) MRI screening in a clinic population with a family history of breast cancer. Ann Surg Oncol 15:452–461

    Article  PubMed  Google Scholar 

  158. Robson M (2004) Breast cancer surveillance in women with hereditary risk due to BRCA1 or BRCA2 mutations. Clin Breast Cancer 5:260–268

    Article  PubMed  Google Scholar 

  159. Gregory-Mercado KY, Will J, True S, Royalty J, Starcher ET, Khavjou O et al (2007) A combined approach to women’s health is associated with a greater likelihood of repeat mammography in a population of financially disadvantaged women. Public Health Res 4:1–9

    Article  Google Scholar 

  160. Wee CC, McCarthy EP, Davis RB, Phillips RS (2000) Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care. Ann Intern Med 132:697–704

    CAS  PubMed  Google Scholar 

  161. Feldman GE (2001) Do Ashkenazi Jews have a higher than expected cancer burden? Implications for cancer control prioritization efforts. Isr Med Assoc J 3:341–346

    CAS  PubMed  Google Scholar 

  162. Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW (2008) A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98:206–209

    Article  CAS  PubMed  Google Scholar 

  163. Anttila A, Koskela J, Hakama M (2002) Programme sensitivity and effectiveness of mammography service screening in Helsinki, Finland. J Med Screen 9:153–158

    Article  CAS  PubMed  Google Scholar 

  164. Gabe R, Tryggvadottir L, Sigfússon BF, Olafsdottir GH, Sigurdsson K, Duffy SW (2007) A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 48:948–955

    Article  CAS  PubMed  Google Scholar 

  165. Council of the European Union (2008) Council conclusions on reducing the burden of cancer. 2876th Employment, Social Policy, Health and Consumer Affairs Council Meeting, Luxembourg, 10 June 2008

  166. Meindl A, German Consortium for Hereditary Breast and Ovarian Cancer (2002) Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population. Int J Cancer 97:472–480

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by the Müllerska Fund through the Royal Swedish Academy of Sciences and by the Signe and Olof Wallenius Stiftelse, Cancerfonden and King Gustav the 5th Jubilee Fund, Sweden, to which the authors are grateful.

Conflict of interest

None of the authors have any conflict of interest regarding this article.

Author information

Authors and Affiliations

  1. Institute of Oncology-Pathology, Karolinska Institute and Hospital, P.O. Box 260, 17176, Stockholm, Sweden

    Karen L. Belkić & Marcela Márquez

  2. School of Community and Global Health, Claremont Graduate University, Claremont, CA, USA

    Karen L. Belkić

  3. Institute for Prevention Research, The Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA

    Karen L. Belkić

  4. Department of Gerontology, Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel

    Miri Cohen

  5. School of Medicine, Autonomous University of Nuevo Leon, Monterrey, N.L., Mexico

    Marcela Márquez

  6. Department of Obstetrics and Gynecology, Karolinska Institute and Hospital, P.O. Box 260, 17176, Stockholm, Sweden

    Miriam Mints

  7. Department of Mammography, Unilabs AB, Sankt Gorans Hospital, Stockholm, Sweden

    Brigitte Wilczek

  8. Department of Clinical Neurosciences, Karolinska Institute and Hospital, P.O. Box 260, 17176, Stockholm, Sweden

    Anne H. Berman

  9. Department of Oncology-Pathology, Karolinska Institute and Hospital, P.O. Box 260, 17176, Stockholm, Sweden

    Enrique Castellanos

  10. Stockholm Ambulatory Care Center, SaltsjoBana, Sweden

    Martha Castellanos

Authors
  1. Karen L. Belkić
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Miri Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marcela Márquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Miriam Mints
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Brigitte Wilczek
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Anne H. Berman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Enrique Castellanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Martha Castellanos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karen L. Belkić.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belkić, K.L., Cohen, M., Márquez, M. et al. Screening of high-risk groups for breast and ovarian cancer in Europe: a focus on the Jewish population. Oncol Rev 4, 233–267 (2010). https://doi.org/10.1007/s12156-010-0056-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12156-010-0056-x

Keywords

Search

Navigation